Article
Silybin acts synergistically with mesenchymal stem cells to ameliorate R848-induced lupus-like disease in mice
2023-08-29
Abstract excerpt
<h4>Objective: </h4> To determine the therapeutic effects of silybin (SBI) and its synergistic effects with mesenchymal stem cells (MSCs) in a lupus mouse model and to explore the therapeutic mechanisms. <h4>Methods:</h4> TLR7/8 agonist resiquimod (R848) was applied for the induction of lupus mice. R848-induced B6 mice were randomly divided into a normal saline control group, SBI group, MSCs group, and SBI plus...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 10402918-b185-57f0-a4f8-d6d1caee5a55
- DOI
- 10.22541/au.169330012.21637314/v1
